Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation

globenewswire.com

Cell Counting - Global Strategic Business Report 2026: Capitalize on US$6 Billion Growth by 2032 as Abbott, Becton Dickinson, Bio-Rad, Danaher, and Sysmex Drive Automation Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Cell Counting - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.

The global cell counting market was valued at US$10.8 billion in 2025 and is projected to reach US$16.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.5%. Market growth is supported by rising demand for automated cell counting systems, increased investment in life sciences research, expansion of biopharmaceutical manufacturing, and the growing use of cell-based analysis in clinical diagnostics and drug development.

Cell Counting Market Trends and Growth Drivers

Cell counting is integral to biotechnology, medical research, diagnostics, and biopharmaceutical production. It supports cell viability assessment, cell culture monitoring, disease research, quality control, and therapeutic development. Demand is particularly strong across oncology, immunology, microbiology, hematology, stem cell research, regenerative medicine, and vaccine production.

The increasing prevalence of cancer, diabetes, infectious diseases, and other chronic conditions is strengthening the need for accurate cellular analysis. Researchers and healthcare providers use cell counting technologies to monitor disease progression, evaluate therapeutic response, and support diagnostic workflows. At the same time, growth in biologics and vaccine manufacturing is increasing demand for precise, reproducible cell counts that help maintain product consistency and quality.

Automated Cell Counting Systems Accelerate Laboratory Workflows

Automated cell counting technologies are gaining adoption because they improve speed, accuracy, reproducibility, and laboratory throughput. Compared with manual processes, automated systems can process larger sample volumes while reducing variability and operator-dependent errors. These capabilities are increasingly important in pharmaceutical research, clinical laboratories, and high-throughput drug discovery programs.

Advanced instruments incorporating imaging, flow cytometry, and integrated data analysis software support complex assays involving heterogeneous cell populations. Their expanding use in oncology, stem cell research, personalized medicine, and regenerative therapies is contributing to sustained market development. User-friendly platforms and streamlined digital workflows are also helping laboratories standardize procedures and improve operational efficiency.

Technology Innovation Reshapes Cell Analysis

Flow cytometry, image-based analysis, microfluidics, and label-free monitoring are advancing the performance and versatility of cell counting solutions. Flow cytometry supports simultaneous counting and characterization of cells, while image-based systems provide detailed information on morphology and viability. Label-free technologies enable real-time cellular monitoring while preserving natural cell behavior.

Artificial intelligence and machine learning are also being integrated into automated cell counting platforms. These technologies can enhance image interpretation, cellular classification, quality control, and analysis of large datasets. Continued innovation is expected to expand the use of cell counting systems across research, clinical diagnostics, and bioprocessing applications.

Market Segment and Regional Outlook

Report Scope

The report analyzes the global cell counting market by value in U.S. dollars and provides annual sales analysis and forecasts from 2025 through 2032.

Strategic Value of the Cell Counting Market Report

Key Questions Addressed

Companies Featured

Domain Expert Insights and Report Differentiators

The outlook for the global cell counting market remains positive as laboratories, healthcare providers, and biopharmaceutical companies prioritize automation, reproducibility, and high-throughput cellular analysis. Continued advances in imaging, flow cytometry, microfluidics, artificial intelligence, and label-free monitoring are expected to broaden applications and support market expansion through 2032.

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/h6vg9e

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.